CryoIQ® cryosurgical devices have been developed using state-of-the-art technologies with the primary goal of improving the quality of cryosurgical treatments of skin lesions for both patients and healthcare practitioners. The company's commitment is to provide affordable, safe and effective care for a wide range of skin conditions in various medical fields, including general medicine, pediatrics, gynecology/urology, podiatry, veterinary medicine and aesthetic applications.

CryoIQ® devices are portable and compact and allow precise and controlled treatment. CryoIQ® devices deliver a fine spray with maximum accuracy to the lesion, maintaining a constant freezing temperature of -89°C / -127°F and freezing power of 725 psi. This cutting-edge technology ensures that treatments for skin lesions with CryoIQ® are fast, safe, cost-effective and do not require anaesthesia.

The versatile CryoIQ® devices come with the option to use either a fixed applicator for common small treatment scenarios, or a range of interchangeable applicators that provide flexibility for a wider variety of treatment options.

One of the key advantages of CryoIQ® is the use of disposable nitrous oxide cartridges. This feature ensures that practitioners have the device on hand for use at all times without the need for time-consuming pre-treatment preparation as is often the case with canisters, liquid nitrogen and other modalities.

All nitrous oxide (N2O) gas cartridges have a built-in leak-free valve and no need to change gas cartridges between patients.

It is important to note that all CryoIQ® products are developed and manufactured in-house and do not rely on external manufacturing sites. This approach provides complete control over the quality and continuous product development process.

Additionally, all CryoIQ® products are manufactured in Sweden, reflecting the company's commitment to excellence and quality in every aspect of our manufacturing and innovation processes.